Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 423.09 Million HKD | 29.93% |
| 2022 | 332.08 Million HKD | -0.47% |
| 2021 | 333.64 Million HKD | 17.69% |
| 2020 | 283.5 Million HKD | -21.43% |
| 2019 | 360.81 Million HKD | -5.15% |
| 2018 | 380.4 Million HKD | 19.34% |
| 2017 | 318.74 Million HKD | 19.12% |
| 2016 | 267.58 Million HKD | 17.16% |
| 2015 | 228.4 Million HKD | 14.48% |
| 2014 | 199.51 Million HKD | 31.44% |
| 2013 | 151.78 Million HKD | 23.99% |
| 2012 | 122.42 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 96.44 Million HKD | -21.61% |
| 2024 Q2 | 96.44 Million HKD | 0.0% |
| 2023 Q1 | 89.69 Million HKD | -7.93% |
| 2023 FY | 431.47 Million HKD | 29.93% |
| 2023 Q3 | 123.47 Million HKD | 37.66% |
| 2023 Q2 | 89.69 Million HKD | 0.0% |
| 2023 Q4 | 123.04 Million HKD | -0.36% |
| 2022 Q3 | 97.42 Million HKD | -32.52% |
| 2022 Q4 | 97.42 Million HKD | 0.0% |
| 2022 Q1 | 72.62 Million HKD | -62.35% |
| 2022 Q2 | 144.36 Million HKD | 98.77% |
| 2022 FY | 332.08 Million HKD | -0.47% |
| 2021 FY | 333.64 Million HKD | 17.69% |
| 2021 Q2 | 156.18 Million HKD | 104.78% |
| 2021 Q3 | 94.18 Million HKD | -39.7% |
| 2021 Q4 | 192.91 Million HKD | 104.83% |
| 2021 Q1 | 76.27 Million HKD | -57.31% |
| 2020 Q1 | 61.7 Million HKD | -66.55% |
| 2020 Q2 | 130.42 Million HKD | 111.36% |
| 2020 Q3 | 80.47 Million HKD | -38.3% |
| 2020 FY | 283.5 Million HKD | -21.43% |
| 2020 Q4 | 178.64 Million HKD | 121.99% |
| 2019 Q4 | 184.48 Million HKD | 98.98% |
| 2019 Q2 | 177.6 Million HKD | 100.29% |
| 2019 Q1 | 88.67 Million HKD | -15.47% |
| 2019 Q3 | 92.71 Million HKD | -47.8% |
| 2019 FY | 360.81 Million HKD | -5.15% |
| 2018 Q4 | 104.9 Million HKD | 0.0% |
| 2018 Q3 | 104.9 Million HKD | 32.97% |
| 2018 Q2 | 78.89 Million HKD | -13.8% |
| 2018 FY | 380.4 Million HKD | 19.34% |
| 2018 Q1 | 91.51 Million HKD | -10.72% |
| 2017 Q3 | 71.37 Million HKD | -4.35% |
| 2017 FY | 318.74 Million HKD | 19.12% |
| 2017 Q2 | 74.62 Million HKD | 6.23% |
| 2017 Q4 | 102.5 Million HKD | 43.62% |
| 2017 Q1 | 70.24 Million HKD | -22.04% |
| 2016 Q4 | 90.1 Million HKD | 42.22% |
| 2016 FY | 267.58 Million HKD | 17.16% |
| 2016 Q3 | 63.35 Million HKD | 13.47% |
| 2016 Q2 | 55.83 Million HKD | -4.21% |
| 2016 Q1 | 58.28 Million HKD | -9.11% |
| 2015 Q2 | 59.21 Million HKD | 16.15% |
| 2015 Q4 | 64.13 Million HKD | 18.63% |
| 2015 Q3 | 54.06 Million HKD | -8.71% |
| 2015 Q1 | 50.98 Million HKD | -27.33% |
| 2015 FY | 228.4 Million HKD | 14.48% |
| 2014 Q3 | 43.74 Million HKD | -11.6% |
| 2014 Q2 | 49.47 Million HKD | 36.93% |
| 2014 Q1 | 36.13 Million HKD | -2.9% |
| 2014 FY | 199.51 Million HKD | 31.44% |
| 2014 Q4 | 70.15 Million HKD | 60.39% |
| 2013 Q1 | 39.93 Million HKD | 11.79% |
| 2013 FY | 151.78 Million HKD | 23.99% |
| 2013 Q2 | 36.41 Million HKD | -8.81% |
| 2013 Q3 | 38.21 Million HKD | 4.93% |
| 2013 Q4 | 37.21 Million HKD | -2.61% |
| 2012 FY | 122.42 Million HKD | 0.0% |
| 2012 Q4 | 35.72 Million HKD | 23.61% |
| 2012 Q1 | 28.25 Million HKD | 0.0% |
| 2012 Q2 | 29.54 Million HKD | 4.56% |
| 2012 Q3 | 28.9 Million HKD | -2.16% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| China Healthwise Holdings Limited | 172.87 Million HKD | -144.744% |
| Tycoon Group Holdings Limited | -15.44 Million HKD | 2838.827% |